Joel Greenblatt's position in Gilead Sciences is currently worth $6.97 Million. That's 0.12% of their equity portfolio (207th largest holding). The first Gilead Sciences trade was made in Q4 2010. Since then Joel Greenblatt bought shares 21 more times and sold shares on 28 occasions. The investor's estimated purchase price is $7.82 Million, resulting in a loss of 11%.